On the contrary, tunicamycin treatment performed on the ALCL derived cell line SU-DHL1 did not result in any reduction of the phosphorylation levels of NPM-ALK, which lacks N-linked glycosylation consensus sites. This evidence concerns the gene ALK and anaplastic large cell lymphoma.